GS
29
-10
FRT
33
-8
FCX
16
-11
DGX
36
-10
CA
13
-3
CCL
37
-6
ALLE
39
11
AVY
46
-2
AES
31
-8
A
30
-4
AAL
26
3
CFG
42
-8
CHRW
50
-6
HOG
33
-3
EQIX
43
-9
BDX
32
-17
DE
42
-4
EL
6
-9
VIX
79
4
AMT
52
-6
GS
29
-10
FRT
33
-8
FCX
16
-11
DGX
36
-10
CA
13
-3
CCL
37
-6
ALLE
39
11
AVY
46
-2
AES
31
-8
A
30
-4
AAL
26
3
CFG
42
-8
CHRW
50
-6
HOG
33
-3
EQIX
43
-9
BDX
32
-17
DE
42
-4
EL
6
-9
VIX
79
4
AMT
52
-6
Financhill
Back

Virtus LifeSci Biotech Clinical Trials ETF Stock Predictions

Crowdfunding to IPO: Nasdaq's Next Breakout?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25

BBC
Virtus LifeSci Biotech Clinical Trials ETF

Last Price:
$15.30
Seasonality Move:
4.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Virtus LifeSci Biotech Clinical Trials ETF Stock Forecast

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 1.1% based on the past 10 years of stock performance.
  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Virtus LifeSci Biotech Clinical Trials ETF Stock Undervalued?
    The current Virtus LifeSci Biotech Clinical Trials ETF [BBC] share price is $15.32. The Score for BBC is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • BBC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Virtus LifeSci Biotech Clinical Trials ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 1.1% based on the past 10 years of stock performance.

Virtus LifeSci Biotech Clinical Trials ETF Stock Rating

Sell
25
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is a Sell

Is Virtus LifeSci Biotech Clinical Trials ETF overpriced?

  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Virtus LifeSci Biotech Clinical Trials ETF Stock Price History

Is BBC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBC is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
31.65
52-Week Low:
15.21

Prediction Charts

Market Cap:
0
Price in USD:
15.32
Volume:
90.4K
Beta:
1.30

Technical Analysis

SMA50:
20.66
SMA100:
23.24
SMA200:
25.48
52-Wk Change:
-43.34%

Stock Predictions

  • Is Virtus LifeSci Biotech Clinical Trials ETF stock public?
    Yes, Virtus LifeSci Biotech Clinical Trials ETF is a publicly traded company.
  • What is the Virtus LifeSci Biotech Clinical Trials ETF stock quote today?
    The Virtus LifeSci Biotech Clinical Trials ETF stock price is 15.32 USD today.
  • How to buy Virtus LifeSci Biotech Clinical Trials ETF stock online?
    You can buy Virtus LifeSci Biotech Clinical Trials ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-18 19.89 19.59 19.89 19.45
Mar-19 19.71 19.98 20.07 19.47
Mar-20 19.77 19.98 20.22 19.71
Mar-21 19.51 19.55 19.83 19.50
Mar-24 19.85 20.03 20.10 19.71
Mar-25 20.05 19.36 20.05 19.24
Mar-26 19.31 18.73 19.33 18.59
Mar-27 19.10 19.07 19.16 18.87
Mar-28 19.08 18.66 19.08 18.57
Mar-31 18.23 17.54 18.23 17.29
Apr-1 17.49 16.53 17.49 16.50
Apr-2 16.37 17.25 17.37 16.37
Apr-3 16.63 16.40 16.70 16.17
Apr-4 15.91 15.32 15.99 15.21

Virtus LifeSci Biotech Clinical Trials ETF Earnings

Data Unavailable

Virtus LifeSci Biotech Clinical Trials ETF Forecast Revenue Growth

Data Unavailable

* Virtus LifeSci Biotech Clinical Trials ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.